COLL
COLLEGIUM PHARMACEUTICAL INC
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 4 parsed filing(s) · 1 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 observed Jul 31, 2026 filed · 31d Initial Schedule 13G | Initial Schedule 13G | 1.6M | 12.00% | $36.20 | $35.39 | |
| Invesco CIK0000914208 | Mar 31, 2026 observed May 8, 2026 filed · 38d Initial Schedule 13G | Initial Schedule 13G | 1.6M +7.0K | 12.00% 0.00 pts | $33.07 | $37.80 | |
| Invesco CIK0000914208 | Jun 30, 2025 observed Aug 7, 2025 filed · 38d Schedule 13G amendment | Earliest Schedule 13G amendment found | 1.6M | 12.00% |